Biomedical research in Ecuador 2016 – 2024: a scoping review of trends, gaps and policy implications
Revista de la Facultad de Ciencias Médicas (Quito) · 31.05.2026 · 51 (2) · 28-44
DOI: 10.29166/rfcmq.v51i2.9215 ↗Kurz gefasst
Scoping Review in der Zeitschrift Revista de la Facultad de Ciencias Médicas (Quito), online erschienen am 31.05.2026. Verfasst von Sandra Malena Alcocer-Veintimilla und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Introduction
Biomedical research is essential for advancing global health; however, disparities persist between high-income countries and low- and middle-income countries regarding scientific production and innovation. In this context, Ecuador faces limitations such as insufficient funding, limited specialized infrastructure, and weak alignment between research and national health priorities. Although some progress and international collaborations exist, biomedical production remains limited in addressing infectious and chronic diseases. This scoping review analyzes translational biomedical research conducted in Ecuador between 2016 and 2024, identifying gaps and challenges to strengthen innovation and support public health decision-making.
Objectives
To map and analyze translational biomedical research published in Ecuador between 2016 and 2024 and identify knowledge gaps and challenges affecting its national applicability.
Methods
A scoping review was conducted following PRISMA-ScR guidelines. Searches were performed in PubMed, Scielo, LILACS, ClinicalTrials.gov, and Cochrane Library using terms related to biomedical research in Ecuador. Studies published in English or Spanish between 2016 and 2024 were included. Three independent reviewers assessed the studies, and a thematic analysis was performed.
Results
Nineteen studies were included. Infectious diseases represented the main research focus (n=9), particularly in post-pandemic contexts. Gastroenterology was another relevant field (n=6), emphasizing minimally invasive innovative interventions. Additional areas included nutrition, traumatology, microbiology, and oncology. Fifteen clinical trials were identified; although nine were completed, only four reported published results, limiting efficacy assessment and evidence availability.
Conclusions
Biomedical research in Ecuador remains fragmented and underrepresented globally. Strengthening research capacity, increasing funding, and promoting the publication of clinical trial results are essential to enhance the country’s scientific and public health impact.
Zitieren
APA
Alcocer-Veintimilla, S. M., Pillajo-Gangotena, V. A., & Gutiérrez-Bravo, M. F. (2026). Biomedical research in Ecuador 2016 – 2024: a scoping review of trends, gaps and policy implications. Revista de la Facultad de Ciencias Médicas (Quito), 51(2), 28-44. https://doi.org/10.29166/rfcmq.v51i2.9215
Vancouver
Alcocer-Veintimilla SM, Pillajo-Gangotena VA, Gutiérrez-Bravo MF. Biomedical research in Ecuador 2016 – 2024: a scoping review of trends, gaps and policy implications. Revista de la Facultad de Ciencias Médicas (Quito). 2026;51(2):28-44. doi:10.29166/rfcmq.v51i2.9215
BibTeX
@article{AlcocerVeintimilla2026,
author = {Alcocer-Veintimilla, Sandra Malena and Pillajo-Gangotena, Víctor Andrés and Gutiérrez-Bravo, María Fernanda},
title = {Biomedical research in Ecuador 2016 – 2024: a scoping review of trends, gaps and policy implications},
journal = {Revista de la Facultad de Ciencias Médicas (Quito)},
year = {2026},
volume = {51},
number = {2},
pages = {28--44},
doi = {10.29166/rfcmq.v51i2.9215}
}
EUVIMED